MapLight Therapeutics Inc.

MPLT | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.90

-$0.02 (-0.18%)

At close: Sep 21, 2026, 4:00 PM ET

$11.20

+$0.30 (+2.75%)

After-hours: Sep 21, 2026, 6:22 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $463.4M

Enterprise Value $159.82M

Beta 2.57

Average Volume 686.31K

Shares Outstanding (Diluted) 45.43M

Shares Change YoY 9.66%

Institutional Ownership 54.55%

Exchange NASDAQ

ISIN US56565P1030

Price Performance

Price Change 1M -2.7%

Price Change 3M -61.9%

Price Change 6M -39.9%

Price Change YTD -35.0%

Price Change 1Y -40.6%

Price Change 3Y -35.6%

Price Change 5Y -35.6%

1M CAGR (ann.) -17.8%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -44.0%

Valuation

PE Ratio -2.10

Forward PE N/A

PEG Ratio 0.03

Forward PEG 0.10

PS Ratio N/A

Forward PS 27.80

PB Ratio 1.33

P/FCF Ratio -2.64

P/Adj. FCF Ratio -2.64

P/OCF Ratio -2.84

EV/Sales N/A

EV/EBIT -0.69

EV/EBITDA -0.69

EV/FCF -0.91

Earnings Yield -47.5%

FCF Yield -37.9%

Adj. FCF Yield -37.9%

Financial Health

Net Cash $303.49M

Total Debt $1.99M

Cash & Short-Term Investments $304.73M

Total Assets $368.35M

Current Ratio 16.52

Quick Ratio 16.52

Debt / Equity Ratio 0.01

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -87.91

Interest Coverage 0.00

Altman Z-Score 10.93

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -0.1%

Returns

Return on Assets -62.4%

Return on Equity -63.8%

Return on Invested Capital -69.3%

Return on Capital Employed -69.6%

Return on Tangible Assets -62.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -50.7%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -47.7%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y 11.6%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $29.20

Price Target Upside 167.9%

Cash Flow

Operating Cash Flow $-174.67M

Free Cash Flow $-175.12M

Adj. Free Cash Flow $-175.25M

FCF Per Share -$3.85

OCF Per Share -$3.84

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-585K

Operating Income $-242.93M

EBITDA $-232.6M

Net Income $-229.83M

EPS (Diluted) -$5.18

Revenue / Employee N/A

Profit / Employee $-1.73M

Employees 133